• Narrowing of the lumen of the carotid arteries, usually caused by atherosclerosis

Incidence:

  • Prevalence of asymptomatic carotid stenosis = 2-18%
  • Up to 20% of pts undergoing CABG may have Carotid Stenosis of > 50%

Aetiology

  • Risk Factors:
    • ↑ Age
    • Smoking
    • HTN
    • IHD
    • TIA
    • DM
    • PVD
    • Cholesterol

Clinical

  • May be asymptomatic
  • TIA (neurological deficit lasting < 24hrs)
    • Amaurosis Fugax = Temporary monocular vision loss caused by a microembolus to the ophthalmic artery
  • Pulsatile tinnitus
  • Hollenhorst Plaques = Small bright flecks in field of vision, due to emboli lodged in arterial bifurcations in the retina
  • Stroke
  • Compared with Vertebrobasilar disease → Emboli in posterior circulation → Vertigo, diplopia, dysphagia & dysequilibirum

Pathology

  • Origin of the ICA & Carotid Sinus is prone to atherosclerosis (change in flow, turbulence & dilatation at this point)
  • Plaques can undergo acute disruption → Thrombus formation & 2° thromboembolism
  • Trigger for acute change in plaque morphology is unknown, but may be related to increased expression of MMP
  • High Risk Features:
    • 90 - 94% Stenosis
    • Irregular / ulcerated plaque

Investigations

  • Duplex USS - 94% sensitive and specific for detecting severe stenoses
    • Flow ratio (velocity) estimates stenosis
  • MRA
  • CTA
  • Angiography = Gold standard – 1 - 4% risk of stroke
    • Absolute indications
      • Technically inadequate duplex
      • Lesion beyond carotid bulb
      • Anatomic variants
    • Relative
      • Unusually high bifurcation
      • Recurrent stenosis
      • Severe fixed neurological deficit
    • Other complications
      • Allergy to contrast < 2%
      • Contrast-induced nephropathy
      • Puncture site problem

Screening

  • Asymptomatic pts > 65yrs with ≥ 3 cardiovascular risk factors but US Preventative Services Task Force (USPSTF) guidelines say that routine screening is not indicated as benefits do not outweigh risks
    • Symptomatic PVD (but not AAA alone)
    • Radiotherapy (≥ 45Gy) for head & neck Ca – screen 10 yrs post-Rx
    • Post-Carotid Endarterectomy – can screen contralateral side, esp. if baseline stenosis ≥50%
    • Renal ischaemic events
      • Not necessarily if just renal artery stenosis

Management

  • Carotid Endarterectomy
    • Oblique anterior SCM incision
    • CCA/ICA/ECA exposed
    • Facial vein transected, lateral retraction of IJV
    • Dissection up to hypoglossal nerve (may need to ligate muscular branches to SCM from ECA & ligate small branches to IJV)
    • CCA/ICA/ECA dissected circumferentially & looped
    • Systemic heparinisation (100U/kg)
    • Sequential clamping ICA, CCA, ECA
    • Monitor ICA stump pressures
    • Anterolateral arteriotomy – common to ICA
      • (Shunt – Javid/ Pruitt)
    • Elevation of plaque with tacking sutures at distal end
    • Primary or vein/gortex patch closure
    • Flush arteriotomy
    • Remove clamps (ECA/CCA/ICA)
    • Skin closure

Indicated for:

  • Symptomatic lesions > 70%
  • Asymptomatic lesions > 60% if operative risk is < 3% & life expectancy is > 5%
  • Decreases stroke risk for symptomatic patients with > 70% stenosis from 26% → 9% at 2 years
    • Some benefit in symptomatic patients with 50-69% stenosis: 22% → 15.7% risk of stroke at 5 yrs
    • NNT= 6 to prevent one stroke / death
  • Asymptomatic lesion
    • Small risk reduction for asymptomatic pts with > 70% stenosis (12% → 6%)
    • ACAS North America & the European ACST
      • NNT=19 to prevent one stroke / death (*)
      • Overall: ≈ 30% risk reduction for stroke over three years (Cochrane 2005)
  • Semi-acute OT – after small TIA / stroke
    • After small stroke in pts ASA I/II: surgery within 2-4 weeks → perioperative stroke risk = 2-7%;
  • but if big stroke / unstable neurological deficit / ASA III or IV → ↑ perioperative stroke risk therefore best to delay surgery by ≈ 6 weeks

General Points

  • Thromboendarterectomy cannot be performed when the ICA completely occluded
  • Coexistent coronary disease treated first
  • Most strokes during cardiac procedure are from atheroma in aortic arch, not low flow through carotids
  • Stroke risk within 30 days = 3%; death rate < 1%
    • May be higher if contralateral occlusion
  • Possible with regional anaesthesia (superficial & deep cervical plexus block – at posterior aspect of SCM) + awake neurological monitoring with selective shunting (only use intra-op shunt in the people who start to develop neurological Sx after cross-clamping)
    • Regional anaesthesia may ↓ strokes, deaths & AMIs
  • Shunting everyone → ↑ complication rates
  • Patch angioplasty (cf primary closure) may ↓ stroke & re-stenosis rates
  • Post-op lose cerebral autoregulation – Keep BP 100-140 Systolic – nitroprusside/ GTN
    • ± Post-op dextran (500mL dextran 40 over 4-6hrs) to ↓ platelet adhesiveness
    • Dextran: Polysaccharide that decreases blood viscosity

Carotid Artery Stenting

  • CAVATAS trial = Carotid artery & vertebral artery transluminal angioplasty & stenting: 500 symptomatic pts RCT
  • Stroke rate ≈ 10% in both arms
  • Trial also not useful because no protection device was used
  • SAPPHIRE = Stenting and angioplasty with protection in pts at high risk for endarterectomy: >300pts; 2/3 were asymptomatic with >80% stenosis
  • Similar results for high risk pts undergoing stenting vs endarterectomy – for death & stroke & for stroke rates at 3yrs
  • Fewer immediate peri-op complications after stenting
  • Results improving (esp. since the intro of cerebral protection devices)
  • Useful for lesions that recur after surgical treatment
  • CREST study: similar results as surgery; higher morbidity in pts >80yrs

Carotid Artery Bypass

  • Rarely used for: long segment atherosclerosis, aneurysm disease, traumatic arterial disruption, re-stenosis after endarterectomy, as part of neck resections

Complications

  • CVA/ Death
  • Haemorrhage
  • Nerve damage
  • Hypoglossal, Ansa Cervicalis, Carotid Sinus nerve
  • Marginal Mandibular
  • Vagus, Recurrent Laryngeal, External Laryngeal
  • Great Auricular, Transverse cervical, Spinal Accessory
  • Glossopharyngeal, Sympathetic

Prognosis / Natural Hx:

  • Stroke risk in symptomatic after 2 yrs → 25-30% (↓ to 2-10% with surgery)
  • Stroke risk lower (≈ 20%) in pts with amaurosis fugax
  • After Bypass:
  • Peri-op stroke & mortality rate = 7.1%
  • 5-yr graft patency rate: 74% for PTFE & 92% for autogenous vein grafts
  • Risk factors for peri-op stroke (& likely to need intra-op shunting)
  • Symptomatic pre-op, includes previous TIAs/AF
  • Pre-op stroke = Highest risk